Showing results (21-30 of 63) with videos related to
Sort By:
Pageof 7
Clinical Medicine. Oncology|September 6, 2011
Oncolytic viruses: do they have a role in anti-cancer therapy?Robin J Prestwich, Fiona Errington, Kevin J Harrington, et al.BJU International|August 5, 2004
Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II studyHardev S Pandha, Robert J John, James Hutchinson, et al.Pigment Cell & Melanoma Research|December 21, 2012
Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expressionAlastair D Mackenzie Ross, Martin G Cook, Heung Chong, et al.Expert Review of Anticancer Therapy|October 18, 2008
Oncolytic viruses: a novel form of immunotherapyRobin J Prestwich, Kevin J Harrington, Hardev S Pandha, et al.Breast Cancer Research and Treatment|October 12, 2012
Targeting the HOX/PBX dimer in breast cancerRichard Morgan, Angie Boxall, Kevin J Harrington, et al.BMC Cancer|February 13, 2016
HOX transcription factors are potential targets and markers in malignant mesotheliomaRichard Morgan, Guy Simpson, Sophie Gray, et al.Human Gene Therapy|July 28, 2009
The case of oncolytic viruses versus the immune system: waiting on the judgment of SolomonRobin J Prestwich, Fiona Errington, Rosa M Diaz, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|September 16, 2010
The effect of cell cycle synchronization on tumor sensitivity to reovirus oncolysisLucy Heinemann, Guy R Simpson, Nicola E Annels, et al.Cancer Immunology, Immunotherapy : CII|December 3, 2003
Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunityStephen M Todryk, Jonathan Eaton, Lindsay Birchall, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2009
Synergistic effects of oncolytic reovirus and cisplatin chemotherapy in murine malignant melanomaHardev S Pandha, Lucy Heinemann, Guy R Simpson, et al.Pageof 7